Journal of Clinical Pathways June 23, 2021
The Centers for Medicare & Medicaid Services (CMS) announced another evaluation report of the Oncology Care Model (OCM) in January 2021,1 covering activities and results for performance periods (PPs) 1 through 5 of 11. In the March 20192 and September 20203 editions of this journal section, authors offered observations based on the previous OCM annual reports. This current article builds upon those observations in light of data from this most recent report published in January 2021, focusing on Medicare spending as well as other performance measures related to the patient experience, management of depression and pain, emergency department (ED) and hospital use, end-of-life (EOL) care, and medication utilization and selection. Insights gained from this performance evaluation...